Antitumor combination including cabazitaxel and capecitabine

Details Antitumor combination including cabazitaxel and capecitabine Antitumor combination including cabazitaxel and capecitabine

A - Human Necessities

61

K

A61K 31/337 (2006.01) A61K 31/7068 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2761079

The invention relates to a pharmaceutical antitumor combination including cabazitaxel and capecitabine, wherein both of said antitumor agents may be in the form of a base, in the form of a pharmaceutically acceptable acid salt or in the form of a hydrate or solvate, intended for the treatment of metastatic breast cancer in patients progressing after a previous treatment with anthracyclines and taxanes.

L'invention est relative à une combinaison pharmaceutique antitumorale comprenant le cabazitaxel et la capecitabine, ces deux agents antitumoraux pouvant être sous forme de base, sous forme d'un sel d'un acide pharmaceutiquement acceptable ou sous forme d'un hydrate ou d'un solvat, destinée à traiter le cancer du sein métastatique chez les patientes progressant après un traitement antérieur par anthracyclines et taxanes.

Affiliated with

Also associated with

Rating

Antitumor combination including cabazitaxel and capecitabine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antitumor combination including cabazitaxel and capecitabine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor combination including cabazitaxel and capecitabine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1767033